Elicera Therapeutics announces participation in several industry and investor meetings in October and November
Gothenburg, October 5, 2021 - Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company that develops immunooncological treatments focusing on CAR T-cells and oncolytic viruses, announced today that the company will attend the following industry and investor meetings in October and November 2021:· ESGCT (European Society of Gene & Cell Therapy) Virtual Congress 2021 – 19-21 oktober 2021 Associate Professor Di Yu, Development Manager at Elicera Therapeutics, will present preclinical data for the company's iTANK platform. · 13th Annual PEGS Europe Summit (Protein &